Citation: | Li Wanli, Zhang Yingying, Zhang Ting, et al. Analysis of key genes and targeted protection methods affecting the survival of human islets[J]. ORGAN TRANSPLANTATION, 2023, 14(2): 273-279. doi: 10.3969/j.issn.1674-7445.2023.02.014 |
[1] |
JIANG H, LI Y, SHEN M, et al. Interferon-α promotes MHC I antigen presentation of islet β cells through STAT1-IRF7 pathway in type 1 diabetes[J]. Immunology, 2022, 166(2): 210-221. DOI: 10.1111/imm.13468.
|
[2] |
周智广. B淋巴细胞亚类与自身免疫糖尿病的胰岛功能[J]. 中华医学信息导报, 2018, 33(23): 13. DOI: 10.3969/j.issn.1000-8039.2018.23.011.
ZHOU ZG. B lymphocyte subclasses and islet function in autoimmune diabetes[J]. Chin Med News, 2018, 33(23): 13. DOI: 10.3969/j.issn.1000-8039.2018.23.011.
|
[3] |
GOU W, WANG J, SONG L, et al. Alpha-1 antitrypsin suppresses macrophage activation and promotes islet graft survival after intrahepatic islet transplantation[J]. Am J Transplant, 2021, 21(5): 1713-1724. DOI: 10.1111/ajt.16342.
|
[4] |
CHEN C, RONG P, YANG M, et al. The role of interleukin-1β in destruction of transplanted islets[J]. Cell Transplant, 2020, 29: 963689720934413. DOI: 10.1177/0963689720934413.
|
[5] |
中华医学会器官移植学分会. 胰岛移植临床技术操作规范(2019版)[J]. 器官移植, 2019, 10(6): 621-627. DOI: 10.3969/j.issn.1674-7445.2019.06.001.
Branch of Organ Transplantation of Chinese Medical Association. Clinical technical operation specification of pancreatic islet transplantation (2019 edition)[J]. Organ Transplant, 2019, 10(6): 621-627. DOI: 10.3969/j.issn.1674-7445.2019.06.001.
|
[6] |
DUGBARTEY GJ. Carbon monoxide in pancreatic islet transplantation: a new therapeutic alternative to patients with severe type 1 diabetes mellitus[J]. Front Pharmacol, 2021, 12: 750816. DOI: 10.3389/fphar.2021.750816.
|
[7] |
HUBBER EL, RACKHAM CL, JONES PM. Protecting islet functional viability using mesenchymal stromal cells[J]. Stem Cells Transl Med, 2021, 10(5): 674-680. DOI: 10.1002/sctm.20-0466.
|
[8] |
YAN LL, YE LP, CHEN YH, et al. The influence of microenvironment on survival of intraportal transplanted islets[J]. Front Immunol, 2022, 13: 849580. DOI: 10.3389/fimmu.2022.849580.
|
[9] |
SONG Y, FENG T, CAO W, et al. Identification of key genes in nasopharyngeal carcinoma based on bioinformatics analysis[J]. Comput Intell Neurosci, 2022: 9022700. DOI: 10.1155/2022/9022700.
|
[10] |
LIU Z, OU C, XIANG S, et al. Expression and regulatory network analysis of BICC1 for aged Sca-1-positive bone narrow mesenchymal stem cells[J]. Dis Markers, 2022: 4759172. DOI: 10.1155/2022/4759172.
|
[11] |
XU X, QI J, YANG J, et al. Up-regulation of TRIM32 associated with the poor prognosis of acute myeloid leukemia by integrated bioinformatics analysis with external validation[J]. Front Oncol, 2022, 12: 848395. DOI: 10.3389/fonc.2022.848395.
|
[12] |
LIU C, LIU J, WU D, et al. Construction of immune-related ceRNA network in dilated cardiomyopathy: based on sex differences[J]. Front Genet, 2022, 13: 882324. DOI: 10.3389/fgene.2022.882324.
|
[13] |
ZHENG H, QIAN X, TIAN W, et al. Exploration of the common gene characteristics and molecular mechanism of Parkinson's disease and Crohn's disease from transcriptome data[J]. Brain Sci, 2022, 12(6): 774. DOI: 10.3390/brainsci12060774.
|
[14] |
STANLEY WJ, TRIVEDI PM, SUTHERLAND AP, et al. Differential regulation of pro-inflammatory cytokine signalling by protein tyrosine phosphatases in pancreatic β-cells[J]. J Mol Endocrinol, 2017, 59(4): 325-337. DOI: 10.1530/JME-17-0089.
|
[15] |
LEBRETON F, HANNA R, WASSMER CH, et al. Mechanisms of immunomodulation and cytoprotection conferred to pancreatic islet by human amniotic epithelial cells[J]. Stem Cell Rev Rep, 2022, 18(1): 346-359. DOI: 10.1007/s12015-021-10269-w.
|
[16] |
DHAYAL S, LESLIE KA, BAITY M, et al. Temporal regulation of interferon signalling in human EndoC-βH1 cells[J]. J Mol Endocrinol, 2022, 69(2): 299-313. DOI: 10.1530/JME-21-0224.
|
[17] |
MOORE F, NAAMANE N, COLLI ML, et al. STAT1 is a master regulator of pancreatic β-cell apoptosis and islet inflammation[J]. J Biol Chem, 2011, 286(2): 929-941. DOI: 10.1074/jbc.M110.162131.
|
[18] |
DOS SANTOS RS, MARROQUI L, VELAYOS T, et al. DEXI, a candidate gene for type 1 diabetes, modulates rat and human pancreatic beta cell inflammation via regulation of the type I IFN/STAT signalling pathway[J]. Diabetologia, 2019, 62(3): 459-472. DOI: 10.1007/s00125-018-4782-0.
|
[19] |
NANO E, PETROPAVLOVSKAIA M, ROSENBERG L. Islet neogenesis associated protein (INGAP) protects pancreatic β cells from IL-1β and IFNγ-induced apoptosis[J]. Cell Death Discov, 2021, 7(1): 56. DOI: 10.1038/s41420-021-00441-z.
|
[20] |
BARRA JM, KOZLOVSKAYA V, KEPPLE JD, et al. Xenotransplantation of tannic acid-encapsulated neonatal porcine islets decreases proinflammatory innate immune responses[J]. Xenotransplantation, 2021, 28(6): e12706. DOI: 10.1111/xen.12706.
|
[21] |
NIGI L, BRUSCO N, GRIECO GE, et al. Pancreatic alpha-cells contribute together with beta-cells to CXCL10 expression in type 1 diabetes[J]. Front Endocrinol (Lausanne), 2020, 11: 630. DOI: 10.3389/fendo.2020.00630.
|
[22] |
ZENG Z, LAN T, WEI Y, et al. CCL5/CCR5 axis in human diseases and related treatments[J]. Genes Dis, 2022, 9(1): 12-27. DOI: 10.1016/j.gendis.2021.08.004.
|
[23] |
CAI XH, WANG GQ, LIANG R, et al. CORM-2 pretreatment attenuates inflammation-mediated islet dysfunction[J]. Cell Transplant, 2020, 29: 963689720903691. DOI: 10.1177/0963689720903691.
|
[24] |
OH E, AHN M, AFELIK S, et al. Syntaxin 4 expression in pancreatic β-cells promotes islet function and protects functional β-cell mass[J]. Diabetes, 2018, 67(12): 2626-2639. DOI: 10.2337/db18-0259.
|
[25] |
YOSHIMATSU G, KUNNATHODI F, SARAVANAN PB, et al. Pancreatic β-cell-derived IP-10/CXCL10 isletokine mediates early loss of graft function in islet cell transplantation[J]. Diabetes, 2017, 66(11): 2857-2867. DOI: 10.2337/db17-0578.
|
[26] |
CHRISTEN U, KIMMEL R. Chemokines as drivers of the autoimmune destruction in type 1 diabetes: opportunity for therapeutic intervention in consideration of an optimal treatment schedule[J]. Front Endocrinol (Lausanne), 2020, 11: 591083. DOI: 10.3389/fendo.2020.591083.
|
[27] |
JAVEED N, HER TK, BROWN MR, et al. Pro-inflammatory β cell small extracellular vesicles induce β cell failure through activation of the CXCL10/CXCR3 axis in diabetes[J]. Cell Rep, 2021, 36(8): 109613. DOI: 10.1016/j.celrep.2021.109613.
|
[28] |
NARDELLI TR, VANZELA EC, BENEDICTO KC, et al. Prolactin protects against cytokine-induced beta-cell death by NFκB and JNK inhibition[J]. J Mol Endocrinol, 2018, 61(1): 25-36. DOI: 10.1530/JME-16-0257.
|
[29] |
ZAMMIT NW, SEEBERGER KL, ZAMERLI J, et al. Selection of a novel AAV2/TNFAIP3 vector for local suppression of islet xenograft inflammation[J]. Xenotransplantation, 2021, 28(3): e12669. DOI: 10.1111/xen.12669.
|
[30] |
ABADPOUR S, TYRBERG B, SCHIVE SW, et al. Inhibition of the prostaglandin D2-GPR44/DP2 axis improves human islet survival and function[J]. Diabetologia, 2020, 63(7): 1355-1367. DOI: 10.1007/s00125-020-05138-z.
|
[31] |
SATO N, HAGA J, ANAZAWA T, et al. Ex vivo pretreatment of islets with mitomycin C: reduction in immunogenic potential of islets by suppressing secretion of multiple chemotactic factors[J]. Cell Transplant, 2017, 26(8): 1392-1404. DOI: 10.1177/0963689717721233.
|
[32] |
KIM G, LEE HS, OH BJ, et al. Protective effect of a novel clinical-grade small molecule necrosis inhibitor against oxidative stress and inflammation during islet transplantation[J]. Am J Transplant, 2021, 21(4): 1440-1452. DOI: 10.1111/ajt.16323.
|
[33] |
FUMAGALLI G, MONFRINI M, DONZELLI E, et al. Protective effect of human mesenchymal stem cells on the survival of pancreatic islets[J]. Int J Stem Cells, 2020, 13(1): 116-126. DOI: 10.15283/ijsc19094.
|
[34] |
WANG K, LI L, JIN J, et al. Fatty acid synthase (Fasn) inhibits the expression levels of immune response genes via alteration of alternative splicing in islet cells[J]. J Diabetes Complications, 2022, 36(6): 108159. DOI: 10.1016/j.jdiacomp.2022.108159.
|
[35] |
FANG C, HUANG Y, PEI Y, et al. Genome-wide gene expression profiling reveals that CD274 is up-regulated new-onset type 1 diabetes mellitus[J]. Acta Diabetol, 2017, 54(8): 757-767. DOI: 10.1007/s00592-017-1005-y.
|
[36] |
CHITTEZHATH M, WAI CMM, TAY VSY, et al. TLR4 signals through islet macrophages to alter cytokine secretion during diabetes[J]. J Endocrinol, 2020, 247(1): 87. DOI: 10.1530/JOE-20-0131.
|
[37] |
BENNER SE, WALTER DL, THUMA JR, et al. Toll-like receptor 3 is critical to the pancreatic islet milieu that is required for coxsackievirus B4-induced type 1 diabetes in female nonobese diabetic mice[J]. Pancreas, 2022, 51(1): 48-55. DOI: 10.1097/MPA.0000000000001960.
|
[38] |
LOKA RS, SONG Z, SLETTEN ET, et al. Heparan sulfate mimicking glycopolymer prevents pancreatic β cell destruction and suppresses inflammatory cytokine expression in islets under the challenge of upregulated heparanase[J]. ACS Chem Biol, 2022, 17(6): 1387-1400. DOI: 10.1021/acschembio.1c00908.
|
[39] |
WANG H, WEI J, HU H, et al. Oral administration of bacterial β cell expansion factor A (BefA) alleviates diabetes in mice with type 1 and type 2 diabetes[J]. Oxid Med Cell Longev, 2022: 9206039. DOI: 10.1155/2022/9206039.
|
[40] |
KWON EY, CHOI MS. Luteolin targets the toll-like receptor signaling pathway in prevention of hepatic and adipocyte fibrosis and insulin resistance in diet-induced obese mice[J]. Nutrients, 2018, 10(10): 1415. DOI: 10.3390/nu10101415.
|
[41] |
CHUNG H, HONG SJ, CHOI SW, et al. High mobility group box 1 secretion blockade results in the reduction of early pancreatic islet graft loss[J]. Biochem Biophys Res Commun, 2019, 514(4): 1081-1086. DOI: 10.1016/j.bbrc.2019.05.003.
|
[42] |
ZHANG J, CHEN L, WANG F, et al. Extracellular HMGB1 exacerbates autoimmune progression and recurrence of type 1 diabetes by impairing regulatory T cell stability[J]. Diabetologia, 2020, 63(5): 987-1001. DOI: 10.1007/s00125-020-05105-8.
|